Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

COMPLETED

Endoscopic Ultrasound-Guided Portosystemic Pressure Gradient Measurements

NCT04668664 · View on ClinicalTrials.gov ↗

Study Summary

The objective of the study is to collect and report technical success of direct endoscopic ultrasound guided hepatic and portal vein pressure measurement obtained with EchoTip® Insight™ in patients with cirrhosis who are referred for an EGD and/or EUS.

Interventions

  • DEVICE EchoTip® Insight™ Portosystemic Pressure Gradient Measurement System (EchoTip® Insight™)

Study Locations (7)

Other

  • Royal Brisbane Women's Hospital — Herston
  • Prince of Wales Hospital/Chinese University of Hong Kong — Shatin

California

  • University of California, Irvine — Orange

Kansas

  • The University of Kansas Health System — Kansas City

Massachusetts

  • Brigham & Women's Hospital — Boston

New York

  • New York-Presbyterian Hospital/Weill Cornell University Medical Center — New York

Virginia

  • University of Virginia Medical Center — Charlottesville

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2021-04-05
Est. Completion 2022-06-13

Sponsor

Cook Research Incorporated

6 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04668664

The ClinicalTrials.gov registry entry for NCT04668664 describes a study currently listed as completed. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cook Research Incorporated, which has 6 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 3 conditions, with Liver Diseases appearing as the primary indexed condition, and to 1 intervention — of which EchoTip® Insight™ Portosystemic Pressure Gradient Measurement System (EchoTip® Insight™) is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT04668664 reports 7 study locations spanning 6 distinct geographic areas — top geographies include Other, California, Kansas. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT04668664 about?

NCT04668664 is a clinical study titled "Endoscopic Ultrasound-Guided Portosystemic Pressure Gradient Measurements". The objective of the study is to collect and report technical success of direct endoscopic ultrasound guided hepatic and portal vein pressure measurement obtained with EchoTip® Insight™ in patients with cirrhosis who are referred for an EGD and/or EUS.

What is the current status of trial NCT04668664?

This trial is currently completed. The enrollment target is 70 participants. The study started on 2021-04-05. Estimated completion is 2022-06-13.

What conditions does trial NCT04668664 study?

This clinical trial studies the following conditions: Liver Diseases, Liver Cirrhosis, Hypertension, Portal. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT04668664?

The interventions under investigation include: EchoTip® Insight™ Portosystemic Pressure Gradient Measurement System (EchoTip® Insight™) (DEVICE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT04668664?

This trial is sponsored by Cook Research Incorporated, which has 6 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT04668664 being conducted?

This trial has 7 study locations across California, Kansas, Massachusetts, New York, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial